# Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)

> **NCT03178812** · NA · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** EUS with fine-needle aspiration of pancreatic cyst
- **DIAGNOSTIC_TEST:** Laboratory Blood test

## Key facts

- **NCT ID:** NCT03178812
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178812, "Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03178812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*